Alyeska Investment Group, L.P. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2020$23,155,000
+96.3%
296,858
+47.2%
0.35%
+49.4%
Q1 2020$11,797,000
+265.8%
201,734
+401.2%
0.24%
+446.5%
Q4 2019$3,225,000
-76.2%
40,252
-76.3%
0.04%
-76.0%
Q1 2019$13,569,000
+78.5%
169,505
+41.5%
0.18%
+163.2%
Q2 2018$7,602,000
+11.8%
119,758
+61.5%
0.07%
+21.4%
Q1 2018$6,800,000
+27.9%
74,156
+5.2%
0.06%
+33.3%
Q4 2017$5,316,000
-23.7%
70,491
-29.5%
0.04%
-19.2%
Q3 2017$6,967,000
+191.6%
100,000
+67.4%
0.05%
+173.7%
Q1 2017$2,389,000
-14.8%
59,746
-40.3%
0.02%
-17.4%
Q4 2016$2,805,000
-24.6%
100,000
-45.6%
0.02%
-34.3%
Q2 2016$3,721,000
+124.4%
183,740
+100.1%
0.04%
+133.3%
Q1 2016$1,658,000
-15.3%
91,837
+23.6%
0.02%
-28.6%
Q4 2015$1,957,000
+9.3%
74,281
-11.5%
0.02%0.0%
Q3 2015$1,791,000
-55.6%
83,914
-45.0%
0.02%
-8.7%
Q2 2015$4,038,000152,4700.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders